In July 2011 the US Food and Drug Administration approved the use of Xarelto (the generic name of Rivaroxaban), an anticoagulant, or blood-thinning, prescription drug that will help: reduce risks of blood clots and stroke in individuals with non-valvular atrial fibrillation; treat deep vein thrombosis and pulmonary embolism effectively, as well as reduce any possibility of their recurrence; and, minimize the risk of blood clot formation in the lungs or legs of people who have just undergone a knee or a total hip replacement surgery.
Bayer Health Care and Johnson & Johnson’s subsidiary Janssen Pharmaceuticals, the joint manufacturers of Xarelto, also intended the drug as an alternative to Warfarin, which has been the standard anti-coagulant medicine in the US since 1954, and to compete with Pradaxa, which the FDA approved in 2010.
Though both Pradaxa and Xarelto are thrombin inhibitors,(a thrombin is a blood plasma enzyme that causes clotting of the blood), they do not contain any form of reversal agent (like vitamin K, which can counteract Warfarin’s bleeding effect) that will stop severe internal bleeding, which is presently the most dangerous, and often lethal, adverse effect of modern anticoagulants. This uncontrollable bleeding case, though, is found to be worse in Xarelto, making it the most common basis of lawsuits filed by individuals who use the drug.
In 2012 more than two thousand cases of severe bleeding were reported to the FDA, with 151 involving patient deaths. According to one non-profit (consumer watchdog) organization, though, Xarelto is linked not only to uncontrollable bleeding, but to a lot of other serious injuries too, including: epidural or spinal hematomas that can result to permanent paralysis; blood in stools and/or in urine; vomiting and/or coughing up of blood; heart-related problems following discontinued use; and so forth.
All across the US (and in other countries around the globe) lawsuits against Xarelto’s manufacturers have started piling, seeking compensation and punitive damages for severe uncontrolled bleeding, wrongful death, marketing of a dangerous drug, failure to warn of adverse effects, etc.
Being represented by Xarelto lawsuit lawyers at the National Injury Law Center would prove to be very advantageous for victims who need a very strong argument in defense of their right and in fighting for their interests. Though the situation and the harm may already be irreversible, receiving the full amount of compensation the victim is legally allowed to will somehow help ease the burden resulting from additional costly medical expenses and possible disability.More →
When travelling at high speeds, a tire explosion can lead to serious injuries or even death. The integrity of a vehicle’s tires can spell the difference between a minor mishap to total wreckage of one or more vehicles, especially in a densely travelled area.
Losing tire tread means loss of control, which can easily lead to a roll over no matter what type of vehicle one is driving when travelling at high speeds. This is because it can result in yawing, which is when the vehicle swings to the side. Loss of control of the vehicle would make it difficult to reverse this sideways motion, causing the vehicle to tip over, possibly involving other vehicles in the immediate vicinity. While the accident may be said to be no one’s fault, liability may accrue to the tire manufacturer, depending on why the blowout occurred. There are several types of tire blowouts resulting from a defect in the manufacturing or design of the tire itself.
Bead failure explosions occur when a design defect affects the tire mounting process. This usually occurs in light truck and passenger tires with a .037 inch weftless configuration. When the bear wire is impeded during inflation, it can exert low pressures that will nevertheless cause the tire to explode at pressures as low as 38 pounds per inch. Such an explosion may result in severe injuries if it occurs close to a flat surface.
Another cause for tire explosions is when there the sidewall of the tire has a defect that will result in a zipper failure. Such incidents often occur when the tire is being inflated, and there is no way to determine if a particular tire has this inherent weakness.
In either case, serious injuries or death can result, and the liability lies with the manufacturer. If such an incident occurs, a report which specifies a defect in the design or manufacture of the tire may be the basis for a product liability lawsuit.More →